BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1975230)

  • 1. Epidemic hemorrhagic fever. The mechanism of coagulation and fibrinolysis.
    Xiang LB; Zhang ZY; Chen JM; Xiang JM; Cosgriff TM
    Chin Med J (Engl); 1990 May; 103(5):391-5. PubMed ID: 1975230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Processes of pathologic coagulation and fibrinolysis in epidemic hemorrhagic fever with renal lesion].
    Gong ZJ; Wu ZO; Guan MY
    Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):39-42, 63. PubMed ID: 2567659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ribavirin on coagulation-anticoagulation in patients with epidemic hemorrhagic fever].
    Wang XJ
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):699-701. PubMed ID: 2907864
    [No Abstract]   [Full Text] [Related]  

  • 6. [A dynamic study of plasminogen, antithrombin III, fibrinogen and DIC in epidemic hemorrhagic fever].
    Xiang LB; Zhang ZY; Chen JM
    Zhonghua Nei Ke Za Zhi; 1988 Dec; 27(12):743-6, 782. PubMed ID: 2907875
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
    Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
    J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
    Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
    Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematological disorders in patients with gastric cancer].
    Yamamura T
    Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):675-85. PubMed ID: 6493191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
    Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
    Wei L; Pan X; Yu Y; Lu Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
    Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
    Bärtsch P; Haeberli A; Straub PW
    Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
    Kaizu K; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.